tradingkey.logo

Alphatec Holdings Inc

ATEC

14.700USD

-0.330-2.20%
Close 09/17, 16:00ETQuotes delayed by 15 min
2.19BMarket Cap
LossP/E TTM

Alphatec Holdings Inc

14.700

-0.330-2.20%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated2025-09-17

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
61 / 207
Overall Ranking
186 / 4723
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 11 analysts
Buy
Current Rating
18.955
Target Price
+26.11%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spine disorders. It has a range of product portfolios designed to address the spine's various pathologies. Its AIX product platform comprises of its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and Valence. The EOS imaging system is designed to provide calibrated full-body imaging that enables a three-dimensional (3D) model of patients’ skeletal systems. It has developed a patient positioning systems that integrates with its other access systems, providing for a more rigid construct and enhanced reproducibility. It offers procedure-specific access systems, including its Sigma-ALIF Access System, which allows for custom anterior abdominal exposure.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 74.30% year-on-year.
Undervalued
The company’s latest PE is -12.98, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 125.22M shares, decreasing 10.68% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 6.63M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.28.

Financial Health

Currency: USD Updated2025-09-17

The company's current financial score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 185.54M, representing a year-over-year increase of 27.46%, while its net profit experienced a year-over-year increase of 1.14%.

Score

Industry at a Glance

Previous score
7.16
Change
0.84

Financials

5.93

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

6.47

Operational Efficiency

10.00

Growth Potential

10.00

Shareholder Returns

7.62

Company Valuation

Currency: USD Updated2025-09-17

The company’s current valuation score is 1.20, which is lower than the Healthcare Equipment & Supplies industry's average of 2.00. Its current P/E ratio is -12.98, which is -41.04% below the recent high of -7.65 and 22.83% above the recent low of -10.01.

Score

Industry at a Glance

Previous score
2.00
Change
-0.8

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 61/207
No Data

Earnings Forecast

Currency: USD Updated2025-09-17

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Alphatec Holdings Inc is 20.00, with a high of 23.00 and a low of 14.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 11 analysts
Buy
Current Rating
18.955
Target Price
+26.11%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

118
Total
7
Median
8
Average
Company name
Ratings
Analysts
Alphatec Holdings Inc
ATEC
11
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
29
1
2
3
...
24

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated2025-09-17

The company’s current price momentum score is 6.29, which is lower than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 16.05 and the support level at 14.00, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.55
Change
-0.26

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.575
Neutral
RSI(14)
42.849
Neutral
STOCH(KDJ)(9,3,3)
7.687
Oversold
ATR(14)
0.533
Low Volatility
CCI(14)
-141.432
Sell
Williams %R
97.561
Oversold
TRIX(12,20)
0.255
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
15.134
Sell
MA10
15.611
Sell
MA20
15.782
Sell
MA50
13.974
Buy
MA100
12.915
Buy
MA200
11.650
Buy

Institutional Confidence

Currency: USD Updated2025-09-17

The company’s current institutional recognition score is 7.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 84.65%, representing a quarter-over-quarter decrease of 5.14%. The largest institutional shareholder is The Vanguard, holding a total of 6.63M shares, representing 4.48% of shares outstanding, with 6.80% increase in holdings.

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Squadron Capital LLC
11.40M
--
BlackRock Institutional Trust Company, N.A.
7.41M
-3.88%
The Vanguard Group, Inc.
Star Investors
5.99M
+0.77%
American Century Investment Management, Inc.
5.83M
+16.86%
L-5 Healthcare Partners LLC
6.07M
-24.92%
Miles (Patrick S)
5.16M
-3.50%
BNP Paribas Asset Management USA, Inc.
4.23M
+13.02%
Braidwell LP
4.26M
+0.07%
State Street Global Advisors (US)
2.83M
-3.07%
Geode Capital Management, L.L.C.
2.51M
+5.24%
1
2

Risk Assessment

Currency: USD Updated2025-09-17

The company’s current risk assessment score is 5.57, which is higher than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 1.07. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
5.57
Change
0
Beta vs S&P 500 index
1.07
VaR
+5.17%
240-Day Maximum Drawdown
+26.02%
240-Day Volatility
+65.00%
Return
Best Daily Return
60 days
+30.15%
120 days
+30.15%
5 years
+39.68%
Worst Daily Return
60 days
-5.09%
120 days
-6.36%
5 years
-34.26%
Sharpe Ratio
60 days
+2.03
120 days
+1.51
5 years
+0.41
Risk Assessment
Maximum Drawdown
240 days
+26.02%
3 years
+73.51%
5 years
+73.51%
Return-to-Drawdown Ratio
240 days
+6.88
3 years
+0.20
5 years
+0.08
Skewness
240 days
+4.14
3 years
+0.71
5 years
+0.52
Volatility
Realised Volatility
240 days
+65.00%
5 years
+63.54%
Standardised True Range
240 days
+3.66%
5 years
+4.20%
Downside Risk-Adjusted Return
120 days
+395.03%
240 days
+395.03%
Maximum Daily Upside Volatility
60 days
+66.38%
Maximum Daily Downside Volatility
60 days
+33.77%
Liquidity
Average Turnover Rate
60 days
+1.48%
120 days
+1.40%
5 years
--
Turnover Deviation
20 days
+28.01%
60 days
+3.06%
120 days
-2.45%

Peer Comparison

Healthcare Equipment & Supplies
Alphatec Holdings Inc
Alphatec Holdings Inc
ATEC
6.30 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
7.91 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
Insulet Corp
PODD
7.86 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stevanato Group SpA
Stevanato Group SpA
STVN
7.84 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Abbott Laboratories
Abbott Laboratories
ABT
7.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Transmedics Group Inc
Transmedics Group Inc
TMDX
7.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI